A clinical study showed that breast cancer patients subjected to radiotherapy and oral administration of EGCG exhibited reduced activation of MMP-9/MMP-2 accompanied with low serum levels of VEGF and hepatocyte growth factor (HGF) [113]. Here, HGF is linked to breast cancer.